The antioxidant tempamine: In vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release

Langmuir

Volumn 23, Issue 4, 2007, Pages 1937-1947

  Wasserman, Veronica ^a   Kizelsztein, Pablo ^a   Garbuzenko, Olga ^a   Kohen, Ron ^b   Ovadia, Haim ^c   Tabakman, Rinat ^b   Barenholz, Yechezkel ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LIPOSOME LIPID COMPOSITION; SYNERGISM; TEMPAMINE;

CELL CULTURE; DRUG PRODUCTS; LIPOSOMES; MIXTURES; PATIENT TREATMENT; PRECIPITATION (CHEMICAL);

AMINES;

AMINE OXIDE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; LIPOSOME; NEUROPROTECTIVE AGENT; TEMPAMINE; UNCLASSIFIED DRUG;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; CANCER TRANSPLANTATION; CHEMISTRY; DRUG EFFECT; ELECTRON SPIN RESONANCE; HUMAN; IC 50; MOUSE; RAT; SURVIVAL RATE; TEMPERATURE; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CYCLIC N-OXIDES; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; INHIBITORY CONCENTRATION 50; LIPOSOMES; MICE; NEOPLASM TRANSPLANTATION; NEUROPROTECTIVE AGENTS; RATS; SURVIVAL RATE; TEMPERATURE; TIME FACTORS;

EID: 33947123224     PISSN: 07437463     EISSN: None     Source Type: Journal    
DOI: 10.1021/la060218k     Document Type: Article

References (32)

1. Afzal, V.; Brasch, R. C.; Nitecki, D. E.; Wolff, S. Nitroxyl spin label contrast enhancers for magnetic resonance imaging. Studies of acute toxicity and mutagenesis. Invest. Radiol. 1984, 19 (6), 549-52.
2. DeGraff, W. G.; Krishna, M. C.; Kaufman, D.; Mitchell, J. B. Nitroxide-mediated protection against X-ray- and neocarzinostatin-induced DNA damage. Free Radical Biol. Med. 1992, 13 (5), 479-87.
3. Mitchell, J. B.; DeGraff, W.; Kaufman, D.; Krishna, M. C.; Samuni, A.; Finkelstein, E.; Ahn, M. S.; Hahn, S. M.; Gamson, J.; Russo, A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, Tempol. Arch. Biochem. Biophys. 1991, 289 (1), 62-70.
4. Samuni, A.; Mitchell, J. B.; DeGraff, W.; Krishna, C. M.; Samuni, U.; Russo, A. Nitroxide SOD-mimics: modes of action. Free Radical Res. Commun. 1991, 12-13 (1), 187-94.
5. Krishna, M. C.; Grahame, D. A.; Samuni, A.; Mitchell, J. B.; Russo, A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc. Natl. Acad. Sci. U.S.A. 1992, 89 (12), 5537-41.
6. Gariboldi, M. B.; Lucchi, S.; Caserini, C.; Supino, R.; Oliva, C.; Monti, E. Antiproliferative effect of the piperidine nitroxide TEMPOL on neoplastic and nonneoplastic mammalian cell lines. Free Radical Biol. Med. 1998, 24 (6), 913-23.
7. Shacter, E.; Williams, J. A.; Hinson, R. M.; Senturker, S.; Lee, Y. J. Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood 2000, 96 (1), 307-13.
8. Abu Raya, S.; Trembovler, V.; Shohami, E.; Lazarovici, P. A tissue culture ischemic device to study eicosanoid release by pheochromocytoma PC 12 cultures. J. Neurosci. Methods 1993, 50 (2), 197-203.
9. Abu-Raya, S.; Bloch-Shilderman, E.; Lelkes, P. I.; Trembovler, V.; Shohami, E.; Gutman, Y.; Lazarovici, P. Characterization of pardaxin-induced dopamine release from pheochromocytoma cells: role of calcium and eicosanoids. J. Pharmacol. Exp. Ther. 1999, 288 (2), 399-406.
10. Tabakman, R.; Lazarovici, P.; Kohen, R. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC 12 cells exposed to ischemia. J. Neurosci. Res. 2002, 68 (4), 463-9.
11. Horowitz, A. T.; Barenholz, Y.; Gabizon, A. A. In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release. Biochim. Biophys. Acta 1992, 1109 (2), 203-9.
12. Reid, S.; Cross, R.; Snow, E. C. Combined Hoechst 33342 and merocyanine 540 staining to examine murine B cell cycle stage, viability and apoptosis. J. Immunol. Methods 1996, 192 (1-2), 43-54.
13. Stein, W. D. Transport and Diffusion Across Cell Membranes; Academic Press: Orlando, FL, 1986; Chapter 1.
14. Clerc, S.; Barenholz, Y. A quantitative model for using acridine orange as a transmembrane pH gradient probe. Anal. Biochem. 1998, 259 (1), 104-11.
15. Samuni, A. M.; Barenholz, Y. Stable nitroxide radicals protect lipid acyl chains from radiation damage. Free Radical Biol. Med. 1997, 22 (7), 1165-74.
16. Haran, G.; Cohen, R.; Bar, L. K.; Barenholz, Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta 1993, 1151 (2), 201-15.
17. Barenholz, Y.; Amselem, S. Quality control assays in the development and clinical use of liposome-based formulations. Liposome Technology, 2nd ed.; Gregoriadis, G., Ed.; Liposome Preparation and Related Techniques; CRC Press: Boca Raton, FL, 1993; Vol. I, pp 527-616.
18. Shmeeda, H.; Even-Chen, S.; Honen, R.; Cohen, R.; Weintraub, C.; Barenholz, Y. Enzymatic assays for quality control and pharmacokinetics of liposome formulations: comparison with nonenzymatic conventional methodologies. Methods Enzymol. 2003, 367, 272-92.
19. Padan, E.; Schuldiner, S. Energy transduction in the photosynthetic membranes of the cyanobacterium (blue-green alga) Plectonema boryanum. J. Biol. Chem. 1978, 253 (9), 3281-6.
20. Dos Santos, N.; Cox, K. A.; McKenzie, C. A.; van Baarda, F.; Gallagher, R. C.; Karlsson, G.; Edwards, K.; Mayer, L. D.; Allen, C.; Bally, M. B. pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol. Biochim. Biophys. Acta 2004, 1661 (1), 47-60.
21. Kohen, R.; Fanberstein, D.; Tirosh, O. Reducing equivalents in the aging process. Arch. Gerontol. Geriatr. 1997, 24 (2), 103-23.
22. Lamson, D. W.; Brignall, M. S. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern. Med. Rev. 1999, 4 (5), 304-29.
23. Modrak, D. E.; Cardillo, T. M.; Newsome, G. A.; Goldenberg, D. M.; Gold, D. V. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer. Cancer Res. 2004, 64 (22), 8405-10.
24. Bauer, V.; Bauer, F. Reactive oxygen species as mediators of tissue protection and injury. Gen. Physiol. Biophys. 1999, 18, 7-14.
25. Samuni, A. M.; Barenholz, Y. Site-activity relationship of nitroxide radical's antioxidative effect. Free Radical Biol. Med. 2003, 34 (2), 177-85.
26. Barenholz, Y. Liposome application: problems and prospects. Curr. Opin. Colloid Interface Sci. 2001, 6, 66-77.
27. Berns, D. S. Protein aggregation in phycocyanin-osmotic pressure studies. Biochem. Biophys. Res. Commun. 1970, 38 (1), 65-73.
28. Barenholz, A.; Fishel, F.; Yakir, E.; Gatt, S.; Barenholz, Y.; Bercovier, H. Liposomes enhance bioremediation of oil-contaminated soil. J. Liposome Res. 2003, 13 (2), 173-86.
29. Suy, S.; Mitchell, J. B.; Ehleiter, D.; Haimovitz-Friedman, A.; Kasid, U. Nitroxides tempol and tempo induce divergent signal transduction pathways in MDA-MB 231 breast cancer cells. J. Biol. Chem. 1998, 273 (28), 17871-8.
30. Hahn, S. M.; Tochner, Z.; Krishna, C. M.; Glass, J.; Wilson, L.; Samuni, A.; Sprague, M.; Venzon, D.; Glatstein, E.; Mitchell, J. B. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res. 1992, 52 (7), 1750-3.
31. Grant, G. J.; Barenholz, Y.; Piskoun, B.; Bansinath, M.; Turndorf, H.; Bolotin, E. M. DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice. Pharm. Res. 2001, 18 (3), 336-43.
32. Lu, F.; Selak, M.; O'Connor, J.; Croul, S.; Lorenzana, C.; Butunoi, C.; Kalman, B. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 2000, 177 (2), 95-103.